Tutkimusnäyttö eri
syöpälajeissa
Paksusuolensyöpä
Werthmann PG, Cysarz D, Jungbluth M, Lederer AK, Nenova G, Huber R, van Dijk M, Kienle GS. Efficacy and safety of massage for postoperative stress in colorectal cancer patients: a randomized, controlled, three-arm trial. Front Oncol. 2025 Feb 5;15:1439420. doi: 10.3389/fonc.2025.1439420. PMID: 39980553; PMCID: PMC11840018.
https://pubmed.ncbi.nlm.nih.gov/39980553/
Cogo, E., Elsayed, M., Bhardwaj, S., Cooley, K., Aycho, C., Liang, V., Papadogianis, P., Psihogios, A., & Seely, D. (2023). Mistletoe Extracts during the Oncological Perioperative Period: A Systematic Review and Meta-Analysis of Human Randomized Controlled Trials. Current Oncology, 30(9), 8196-8219. https://www.mdpi.com/1718-7729/30/9/595
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529072/pdf/curroncol-30-00595.pdf
Baek JH, Jeon Y, Han KW, Jung DH, Kim KO: Effect of mistletoe extract on tumor response in neoadjuvant chemoradiotherapy for rectal cancer: a cohort study. World Journal of Surgical Oncology 2021, 19 (1):178. 10 pp. DOI: 10.1186/s12957-021-02293-4
Ostermann T, Appelbaum S, Poier D, Boehm K, Raak C and Büssing A. A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings. Complement Med Res. 2020 Jan 10:1-12. doi: 10.1159/000505202.
Kts. lisätietoja julkaisijan sivuilta
Bock PR, Hanisch J, Matthes H and Zänker KS. Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients. Inflamm Allergy Drug Targets, 2014;13:105-11142.
von Schoen-Angerer, T, Goyert, A, Vagedes, J, Kiene, H, Merckens, H, Kienle, GS. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report. J Gastrointestin Liver Dis. 2014;23(4):449-452. doi:10.15403/jgld.2014.1121.234.acpy
Google Scholar | Crossref | Medline
Zänker KS, Matthes H, Bock PR, Hanisch J.A Specific Mistletoe Preparation (Iscador-Qu®) in Colorectal Cancer (CRC) Patients: More than Just Supportive Care? J Cancer Sci Ther 2012;4:264-270. doi: 10.4172/1948-5956.1000153
Friedel WE, Matthes H, Bock PR and Zänker KS. Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study. J Soc Integr Oncol 2009;7:137-145
Schink M, Tröger W, Goyert A, Scheuerecker H, Meyer J, Fischer I and Glaser F (2009). Einfluss perioperativer Mistelextrakt-Infusionen auf eine operations- und narkosebedingte Immunsuppression bei Patienten mit kolorektalem Karzinom. S. 441-454. Die Mistel in der Tumortherapie 2. R. Scheer, S. Alban, H. Becker et al. Essen, KVC Verlag. 2009: S. 441-454.
Enesel MB, Acalovschi I, Grosu V et al. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients. Anticancer Research 2005;25(6):4583–4590.
Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested
within a cohort study. Altern Ther Health Med. 2001 May-Jun; 7(3): 57–66.
Leroi R. Die Iscadorbehandlung bei inoperablen kolo-rektalen Tumoren. Krebsgeschehen. 1979; 11(6): 163–5.